Phase 3 Meningitis Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
Cryptococcal Meningitis
Makerere University356 enrolled1 locationNCT03945448
Recruiting
Phase 2Phase 3
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Phase 2Phase 3
Platform Trial For Cryptococcal Meningitis
HIVCryptococcal Meningitis
University of Minnesota2,000 enrolled2 locationsNCT06666322
Recruiting
Phase 3
Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Tuberculous Meningitis
ANRS, Emerging Infectious Diseases768 enrolled13 locationsNCT04145258